Business
Vaccine ‘not a panacea’ as surgeries bounce back: Cochlear boss – Sydney Morning Herald
The hearing implant maker is still on the long path back to a COVID normal but can see some light at the end of the tunnel.
When asked exactly how long it will be before all markets had recovered to the same or better levels than before the pandemic, Mr Howitt said it was more likely to be years than months. I think the thing is that the bigger markets where we are in have bounced back quickly, so that is what gives us some confidence. But I think the tail could be quite long.
Cochlears sales in emerging regions, including Latin America and Brazil, were down 30 per cent for the first half (year-on-year), while sales…
-
Noosa News24 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business18 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General23 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Noosa News20 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal